BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 22, 2011
View Archived Issues
Tamsulosin OCAS plus solifenacin in BPH-associated LUTS: SATURN results disclosed at EAU meeting
Read More
Marine product NPM-01 has neuroprotective activity
Read More
Chloroquine inhibits pancreatic tumor growth by suppressing autophagy
Read More
Researchers at the MCG Research Institute present novel modulators of F1F0 ATP synthase
Read More
Nektar begins phase I trial of NKTR-181 for the treatment of pain
Read More
European Commission approves Jevtana for second-line treatment of prostate cancer
Read More
FDA approves IND for StarGen, a novel ocular product for Stargardt's disease
Read More
Galanin GAL1 receptor agonists developed by High Point Pharmaceuticals for pain
Read More
Gilenya gains approval in Europe for multiple sclerosis
Read More
Janssen discloses novel inhibitors of fatty-acid amide hydrolase
Read More
Merck & Co. patents new mGlu2 receptor agonists for schizophrenia
Read More
Merck & Co. prepares new series of PDE10A inhibitors
Read More
S*BIO's SB-939 to enter advanced lung cancer trials in Singapore
Read More
Mucosis begins phase I study of FluGEM vaccine
Read More
Hunter Immunology begins phase IIb study of HI-164OV oral vaccine in COPD
Read More
CHMP recommends approval of Eliquis for prevention of venous thromboembolic events
Read More
EMA committee recommends new pediatric indication for Pfizer's Revatio
Read More
Curemark achieves enrollment target for phase III trials of autism therapy CM-AT
Read More
CHMP adopts positive opinion on ViroPharma's Cinryze
Read More
Photocure's Cevira PDT to be assessed in phase II trial
Read More
NanoViricides reports survival data from latest animal study of FluCide drug candidates
Read More
FDA clears Insmed's IND for phase III Arikace trial in mycobacterial lung infections
Read More
Medicago begins U.S. phase I trial of H1N1 influenza vaccine candidate
Read More
PAI-039 improves symptoms of inflammation in experimental model of chronic asthma
Read More
Calcitriol activity may prevent steroid-resistant asthma
Read More